Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00975429
What this trial is testing

Study Using WST11 in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Steba Biotech S.A. 86
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Early research (Phase 1)Ended earlyNCT03066154
What this trial is testing

Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Netherlands Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT00477529
What this trial is testing

ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Celgene 102
Not applicableActive Not RecruitingNCT00760331
What this trial is testing

Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function

Who this might be right for
Hepatocyte Nuclear Factor 1-beta
University Hospital, Limoges 100
Early research (Phase 1)Study completedNCT01832870
What this trial is testing

Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

Who this might be right for
Prostate CancerCastrate Resistant Prostate Cancer
Prostate Oncology Specialists, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT00738673
What this trial is testing

Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 37
Not applicableNot Yet RecruitingNCT07580651
What this trial is testing

Quality and Safety of Real-Time Brachytherapy Treatments: Clinical Implementation of a Multipoint Scintillation Detector for Treatment Monitoring

Who this might be right for
Prostate CancerGynecologic Cancers
CISSS de Chaudière-Appalaches 20
Early research (Phase 1)Study completedNCT04428203
What this trial is testing

Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate CancerProstate Adenocarcinoma
Zin W Myint 21
Testing effectiveness (Phase 2)Study completedNCT00425503
What this trial is testing

PS-341 Followed by Removal of Prostate for Those With Prostate Cancer

Who this might be right for
Prostate Neoplasms
Baylor College of Medicine 40
Not applicableStudy completedNCT04827446
What this trial is testing

Lighting Intervention for Cancer-related Fatigue

Who this might be right for
Breast CancerProstate CancerHematologic Malignancy+2 more
University of Michigan Rogel Cancer Center 139
Testing effectiveness (Phase 2)Study completedNCT00686088
What this trial is testing

An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy

Who this might be right for
Locally Recurrent Prostate Cancer
Sophiris Bio Corp 30
Testing effectiveness (Phase 2)Study completedNCT00973882
What this trial is testing

Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers

Who this might be right for
Prostate Cancer
Centre Leon Berard 60
Testing effectiveness (Phase 2)Study completedNCT03077659
What this trial is testing

Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
NanOlogy, LLC 16
Not applicableUnknownNCT00670527
What this trial is testing

[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases

Who this might be right for
Prostate Cancer
Odense University Hospital 205
Post-approval studies (Phase 4)UnknownNCT00906269
What this trial is testing

Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer

Who this might be right for
ImpotenceProstatic Neoplasms
Hartford Hospital 100
Not applicableStudy completedNCT03160794
What this trial is testing

Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy

Who this might be right for
Post Prostatectomy
University Health Network, Toronto 150
Testing effectiveness (Phase 2)Study completedNCT00707356
What this trial is testing

Study of WST11 in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Steba Biotech S.A. 42
Not applicableStudy completedNCT07477756
What this trial is testing

A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 1,247
Not applicableUnknownNCT02964351
What this trial is testing

MicroRNA Profiles Identification in Adeno Carcinoma Prostate Cancer

Who this might be right for
Prostate Carcinosarcoma
Assuta Medical Center 120
Next Page